- Australian Open entry list: Nadal in with protected ranking, No. 97 cutoff
- Tim Henman Plays Tennis for 24 Hours to Benefit Children’s Charity
- Caroline Wozniacki and Six Aussies Receive 2024 Australian Open Wild Cards
- 2024 Brisbane event includes Nadal, Murray, Dimitrov, and Osaka
- Rafael Nadal Announces Brisbane Return
- Alicia Molik Named Adelaide International Tournament Director
- Defending Champion Tiafoe Returning for U.S. Men’s Clay Court Championship
- Including doubles, Sinner defeats Djokovic three times in 11 days
- Sinner the hero as Italy captures first Davis Cup title since 1976
- Dana Mathewson Wins Two Gold Medals at the Parapan American Games
- Gambill: Wayne Arthurs One of Top 3 Servers
- Davis Cup Finals Draws and Schedule for Sunday, November 26, 2023
- Stars Set for LA Tennis Bash on December 9th to Benefit First Break Academy
- SOLINCO NEW RACQUETS THE WHITEOUT AND BLACKOUT XTD+
- Serbia and Italy advance to Davis Cup semis, setting up another Djokovic vs. Sinner showdown
Tennis Anti-Doping Program Statement Regarding Daniel Evans
- Updated: July 3, 2017
Following the statement made by Daniel Evans today, the Tennis Anti-Doping Programme (TADP) can confirm the following:
- On 24 April 2017, Mr Evans, a 27-year-old player from Great Britain, provided an anti-doping sample to the TADP in association with his participation in the Barcelona Open, an ATP World Tour event, held in Barcelona, Spain.
- That sample was analysed by a World Anti-Doping Agency (WADA) accredited laboratory in Montreal, Canada, and was found to contain cocaine and its metabolite. Cocaine is a Non-Specified substance prohibited under category S6 of the 2017 WADA Prohibited List (stimulants), and therefore is also prohibited under the TADP.
- In accordance with Article 2.1 of the TADP, Mr Evans was charged on 16 June with an Anti-Doping Rule Violation.
- Mr Evans has accepted the finding of cocaine in his sample collected on 24 April.
- As positive tests for Non-Specified Substances carry a mandatory Provisional Suspension, Mr Evans will be provisionally suspended with effect from 26 June, under Article 8.3.1(c) of the 2017 TADP, pending determination of the case.
The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the Tennis Anti-Doping Programme and World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping.